Novanta
NOVT · NASDAQ · Technology
$133.14
$0.41 (-0.31%) today
Market Cap
$5.04B
24h Volume
$107.6M
P/E Ratio
84.3
52w High
$168.75
52w Low
$99.22
Est. AI Revenue
10%
7-Day Sparkline (Static)
Company facts
Performance
About Novanta
Novanta supplies the components inside intelligent machines. The company sells photonics, machine vision, and precision motion subsystems to medical and advanced industrial equipment makers, earning revenue as an OEM supplier whose parts are designed into products like surgical robots, laser processing systems, and warehouse automation.
Its portfolio includes laser beam steering from Cambridge Technology, machine vision and data capture from JADAK, and precision encoders and motion control from Celera Motion. These subsystems handle the seeing and moving that robots depend on, sitting one layer below the AI software that directs them.
Founded in 1968 as General Scanning and renamed Novanta in 2016, the company is headquartered in Bedford, Massachusetts, employs about 3,000 people, and trades on the NASDAQ.
Novanta in the AI buildout
Novanta plays a picks and shovels role in the Robotics layer, supplying the optics, vision, and motion subsystems that robot OEMs build around. It does not sell AI products of its own; its exposure comes from unit growth in robotic surgery, warehouse automation, and industrial robots, all markets pulled forward by AI capability. As machines gain autonomy they need more precise sensing and motion, which raises Novanta's content per system even though the intelligence itself lives elsewhere.
NOVT is tracked in Robotics & Automation, rated Growing on the AI Exposure leaderboard.
By the numbers
52-week range
NOVT trades at $133.14, 49% of the way up its 52-week range of $99.22 to $168.75.
Market cap
Market capitalization is $5.04B, with an AI Exposure Score of 40 out of 100.
Valuation vs peers
Its P/E ratio of 84.3 is above the Robotics & Automation category median of 35.9.
Next earnings
Novanta is next expected to report earnings on November 3, 2026.
Market data as of the close on . Prices are end of day, not live.
Frequently asked questions
What does Novanta do?
Novanta supplies photonics, machine vision, and precision motion components to makers of medical and industrial equipment. Its subsystems go inside surgical robots, laser processing systems, warehouse automation, and industrial robots, sold through OEM relationships that persist across product generations.
How is Novanta exposed to AI?
Indirectly. Novanta sells enabling components to robot and automation OEMs rather than AI products of its own, so its exposure rides on unit growth in intelligent machines. Supercycle rates it Growing with an AI Exposure Score of 40 out of 100.
Is NOVT a pure play AI stock?
No. Novanta is a diversified component supplier whose markets include medical devices and industrial equipment with no AI content. Supercycle places it in the Growing tier: robotics driven demand is real, but the business does not depend on the AI buildout.
What products does Novanta make?
Key lines include Cambridge Technology laser beam steering, Synrad lasers, JADAK machine vision and data capture, and Celera Motion precision encoders and motion subsystems. Customers integrate these into robotic surgery platforms, laser material processing tools, and automation equipment.
Who leads Novanta?
Matthijs Glastra has served as chief executive since 2016, leading the company's shift toward medical and advanced industrial growth markets through targeted acquisitions and the Novanta Growth System, its operating model for integrating and improving acquired businesses.
Profile written 2026-08, updated as the business changes. Editorial content, not investment advice.